Development of a real time PCR assay for the JAK2V617F mutation in myeloproliferative disorders

被引:0
|
作者
Olsen, RJ
Tang, D
Bernard, DW
Farkas, DH
Chang, JCC
机构
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Cornell Univ, Ithaca, NY USA
[3] Methodist Hosp, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
1115
引用
收藏
页码:240A / 240A
页数:1
相关论文
共 50 条
  • [21] EPIGENETIC CHANGES IN JAK2V617F POSITIVE MYELOPROLIFERATIVE DISORDERS
    Uras, A.
    Fancello, M. A.
    Monne, M.
    Piras, G.
    Palmas, A. D.
    Gaviano, E.
    Noli, A.
    Bianchi, A.
    Gabbas, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 356 - 356
  • [22] Myeloproliferative disorders with coexisting BCR-ABL translocation and JAK2V617F mutation
    Go, R. S.
    LEUKEMIA, 2007, 21 (09) : 2051 - 2051
  • [23] MassARRAY assay: a more accurate method for JAK2V617F mutation detection in Chinese patients with myeloproliferative disorders
    Fu, J-F
    Shi, J-Y
    Zhao, W-L
    Li, G.
    Pan, Q.
    Li, J-M
    Hu, J.
    Shen, Z-X
    Jin, J.
    Chen, F-Y
    Chen, S-J
    LEUKEMIA, 2008, 22 (03) : 660 - 663
  • [24] JAK2V617F mutation and myeloproliferative disorders in splanchnic vein thrombosis: authors' reply
    Westbrook, R. H.
    Mufti, G.
    Heneghan, M. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (04) : 496 - 497
  • [25] MassARRAY assay: a more accurate method for JAK2V617F mutation detection in Chinese patients with myeloproliferative disorders
    J-F Fu
    J-Y Shi
    W-L Zhao
    G Li
    Q Pan
    J-M Li
    J Hu
    Z-X Shen
    J Jin
    F-Y Chen
    S-J Chen
    Leukemia, 2008, 22 : 660 - 663
  • [26] Myeloproliferative disorders with coexisting BCR-ABL translocation and JAK2V617F mutation
    R S Go
    Leukemia, 2007, 21 : 2051 - 2051
  • [27] COMPARATIVE EVALUATION OF REAL-TIME PCR ASSAYS FOR JAK2V617F MUTATION: STEP TOWARDS ASSAY HARMONIZATION
    Pancrazzi, A.
    Guglielmelli, P.
    Biamonte, F.
    Antonioli, E.
    Bosi, A.
    Barbui, T.
    Vannucchi, A. M.
    HAEMATOLOGICA, 2008, 93 : S60 - S61
  • [28] Quantification of JAK2V617F mutation burden by droplet digital PCR in patients with myeloproliferative neoplasms
    Ivanov, H. Y.
    Linev, A.
    Zheliazkov, I.
    Graklanov, V.
    Beleva, E.
    Goranova-Marinova, V.
    Grudeva-Popova, Z.
    Stoyanova, V.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 537 - 538
  • [29] Underlying mechanisms of the JAK2V617F mutation in the pathogenesis of myeloproliferative neoplasms
    Mullally, A.
    PATHOLOGE, 2016, 37 : 175 - 179
  • [30] JAK2V617F mutation in leukaemic transformation of philadelphia-negative chronic myeloproliferative disorders
    Rossi, Davide
    Deambrogi, Clara
    Capello, Daniela
    Cerri, Michaela
    Lunghi, Monia
    Parvis, Guido
    Saglio, Giuseppe
    Gaidano, Gianluca
    Cilloni, Daniela
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (02) : 267 - 268